Literature DB >> 3513873

A simplified functional assay for protein C in plasma samples.

W Thiel, K T Preissner, U Delvos, G Müller-Berghaus.   

Abstract

The important role of protein C (PC) in the regulation of hemostasis has been appreciated since the description of patients who were deficient in PC and presented with severe thromboembolic events. The potentially fatal complications associated with PC-deficiency require an early and reliable identification of those patients affected with this inherited disorder. The present study introduces a test procedure for the functional assessment of PC in plasma samples. The test utilizes the thrombin/thrombomodulin complex to achieve complete and rapid formation of activated PC whose proteolytic capacity is subsequently determined with a chromogenic substrate. Homogenate obtained from rabbit lung effectively substituted the purified component thrombomodulin in the assay system. This new approach simplifies the test procedure without losing specificity and accuracy. Proteases, such as plasmin, streptokinase and urokinase did not influence the assay and the inhibitory effect of heparin on the PC-activation could easily be overcome by the addition of protamine sulphate. The PC-activity in a group of unselected patients (n = 50), who did not reveal any abnormalities in global coagulation tests, amounted to 100 +/- 12% (mean +/- SD) with a range from 54 to 143% when analyzed in comparison to a plasma pool constituted from healthy volunteers. Since the synthesis of PC depends on the availability of vitamin K, patients receiving phenprocoumon have also been analyzed. These patients (n = 103) presented 40 +/- 11% residual PC-activity accompanied by a concomitant decrease in PC-antigen levels to 43 +/- 10% (mean +/- SD). The test described is specific, sensitive, less time-consuming and can be performed on a routine basis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3513873     DOI: 10.1007/bf00320533

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  24 in total

1.  Proteolytic formation and properties of gamma-carboxyglutamic acid-domainless protein C.

Authors:  N L Esmon; L E DeBault; C T Esmon
Journal:  J Biol Chem       Date:  1983-05-10       Impact factor: 5.157

2.  Identification of an endothelial cell cofactor for thrombin-catalyzed activation of protein C.

Authors:  C T Esmon; W G Owen
Journal:  Proc Natl Acad Sci U S A       Date:  1981-04       Impact factor: 11.205

3.  Familial protein S deficiency is associated with recurrent thrombosis.

Authors:  P C Comp; R R Nixon; M R Cooper; C T Esmon
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

4.  Neonatal purpura fulminans: a genetic disorder related to the absence of protein C in blood.

Authors:  E Marciniak; H D Wilson; R A Marlar
Journal:  Blood       Date:  1985-01       Impact factor: 22.113

5.  Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation.

Authors:  C T Esmon; N L Esmon; K W Harris
Journal:  J Biol Chem       Date:  1982-07-25       Impact factor: 5.157

6.  Proteolytic activation of protein C from bovine plasma.

Authors:  W Kisiel; L H Ericsson; E W Davie
Journal:  Biochemistry       Date:  1976-11-02       Impact factor: 3.162

7.  A functional assay for protein C in human plasma.

Authors:  R B Francis; M J Patch
Journal:  Thromb Res       Date:  1983-12-15       Impact factor: 3.944

8.  A functional assay of protein C in human plasma.

Authors:  N Sala; W G Owen; D Collen
Journal:  Blood       Date:  1984-03       Impact factor: 22.113

9.  Determination of functional levels of protein C, an antithrombotic protein, using thrombin-thrombomodulin complex.

Authors:  P C Comp; R R Nixon; C T Esmon
Journal:  Blood       Date:  1984-01       Impact factor: 22.113

10.  Activated protein C decreases plasminogen activator-inhibitor activity in endothelial cell-conditioned medium.

Authors:  V W van Hinsbergh; R M Bertina; A van Wijngaarden; N H van Tilburg; J J Emeis; F Haverkate
Journal:  Blood       Date:  1985-02       Impact factor: 22.113

View more
  2 in total

1.  Heterozygous protein C deficiency type I.

Authors:  B Kemkes-Matthes
Journal:  Blut       Date:  1989-04

2.  Increased tissue-plasminogen activator (t-PA) levels in patients under oral anticoagulant therapy.

Authors:  J Grulich-Henn; K Loechelt; W Speiser; G Müller-Berghaus
Journal:  Blut       Date:  1989-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.